SLU-PP-332 500mcg – 50 Tablets

SLU-PP-332 is a synthetic small molecule agonist of estrogen related receptors alpha and gamma (ERRα and ERRγ). Orphan nuclear receptors that regulate mitochondrial biogenesis, oxidative metabolism, and skeletal muscle energy substrate utilization without interacting with classical estrogen receptors. F40 Biotech’s formulation delivers 500mcg per tablet in a 50 count oral format. A precisely dosed presentation suited to the low concentration range at which ERR agonist activity has been documented in preclinical research models examining metabolic adaptation and exercise mimetic activity.

SLU-PP-332’s mechanism of action through ERRα and ERRγ co activation produces a coordinated upregulation of oxidative phosphorylation gene expression, mitochondrial biogenesis, and fatty acid oxidation pathway activity in skeletal muscle tissue, biological responses that closely mirror the transcriptional adaptations produced by endurance exercise training. This exercise mimetic profile has positioned SLU-PP-332 as one of the most actively discussed small molecule research compounds in contemporary metabolic science, with preclinical research documenting increased running endurance, enhanced oxidative muscle fiber characteristics, and improved metabolic flexibility in animal models. The ERR receptor pathway targeted by SLU-PP-332 is distinct from the AMPK pathway activated by compounds like MOTS-C and 5-Amino-1MQ; making it a complementary rather than redundant research tool in studies examining different molecular entry points into exercise adaptive metabolic regulation.

The oral tablet format is particularly well suited to SLU-PP-332 as a small molecule compound, unlike peptide research compounds that face gastrointestinal degradation requiring parenteral or intranasal delivery, small molecule ERR agonists are designed for oral bioavailability with gastrointestinal absorption and systemic distribution from standard tablet administration. At 500mcg per tablet this formulation provides precise low dose titration capability across research protocols examining ERR agonist dose response relationships in oxidative metabolism and mitochondrial biogenesis endpoints.

F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and F40 Biotech’s SLU-PP-332 meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Store in a cool, dry place away from direct light and heat. Intended for research purposes only.

Commonly researched alongside MOTS-C and 5-Amino-1MQ in comparative metabolic regulation and exercise mimetic compound studies. Browse CSD’s full peptide and research compound range for complete sourcing.